Trpc1 ion channel modulates phosphatidylinositol 3-kinase/Akt pathway during myoblast differentiation and muscle regeneration - PubMed (original) (raw)

Trpc1 ion channel modulates phosphatidylinositol 3-kinase/Akt pathway during myoblast differentiation and muscle regeneration

Nadège Zanou et al. J Biol Chem. 2012.

Abstract

We previously showed in vitro that calcium entry through Trpc1 ion channels regulates myoblast migration and differentiation. In the present work, we used primary cell cultures and isolated muscles from Trpc1(-/-) and Trpc1(+/+) murine model to investigate the role of Trpc1 in myoblast differentiation and in muscle regeneration. In these models, we studied regeneration consecutive to cardiotoxin-induced muscle injury and observed a significant hypotrophy and a delayed regeneration in Trpc1(-/-) muscles consisting in smaller fiber size and increased proportion of centrally nucleated fibers. This was accompanied by a decreased expression of myogenic factors such as MyoD, Myf5, and myogenin and of one of their targets, the developmental MHC (MHCd). Consequently, muscle tension was systematically lower in muscles from Trpc1(-/-) mice. Importantly, the PI3K/Akt/mTOR/p70S6K pathway, which plays a crucial role in muscle growth and regeneration, was down-regulated in regenerating Trpc1(-/-) muscles. Indeed, phosphorylation of both Akt and p70S6K proteins was decreased as well as the activation of PI3K, the main upstream regulator of the Akt. This effect was independent of insulin-like growth factor expression. Akt phosphorylation also was reduced in Trpc1(-/-) primary myoblasts and in control myoblasts differentiated in the absence of extracellular Ca(2+) or pretreated with EGTA-AM or wortmannin, suggesting that the entry of Ca(2+) through Trpc1 channels enhanced the activity of PI3K. Our results emphasize the involvement of Trpc1 channels in skeletal muscle development in vitro and in vivo, and identify a Ca(2+)-dependent activation of the PI3K/Akt/mTOR/p70S6K pathway during myoblast differentiation and muscle regeneration.

PubMed Disclaimer

Figures

FIGURE 1.

FIGURE 1.

Weight and tension of normal and regenerating muscle in Trpc1+/+ and Trpc1−/− mice. A and B, animal and EDL muscle weights during the first 6 months of life (*, p < 0.05). C, maximal tension (force per cross-sectional area) measured after cardiotoxin-induced injury in EDL muscles at day 14 of regeneration, stimulated during 300 ms and at 125 Hz. *, p < 0.05 versus Trpc1+/+ (Student's t test, n = 6). D, time course of muscle tension in regenerating EDL muscles. Day zero is the day of cardiotoxin injection. Tension of regenerating muscle reported to that of contralateral noninjected muscle. *, p < 0.05 versus Trpc1+/+ (two-way analysis of variance followed by Tukey's test for multiple comparison, n = 6 per day).

FIGURE 2.

FIGURE 2.

Histological characteristics of regenerating muscles after cardiotoxin injection. A, hematoxylin/eosin staining of TA muscles from Trpc1**+/+** and Trpc1−/− mice after cardiotoxin injection. B, detailed views of zones represented at day 10. Shown is a quantification of fiber size areas. *, p < 0.05 versus Trpc1+/+ (Pearson Chi square, n = 6 different mice). C, fiber size at day (D) 10 of regeneration related to contralateral noninjected muscle (*, p < 0.05, n = 6 TA muscles from six different mice, 200 fibers counted per muscle). D, detailed views of zones represented at day 14. The proportion of central nuclei is shown. Arrows indicate central nuclei. ***, p < 0.001 versus Trpc1+/+ (n = 3 different mice, three microscopic fields per muscle of each animal).

FIGURE 3.

FIGURE 3.

Assessment of the activity of myogenic transcription factors. A, immunodetection of MHCd in TA muscles from Trpc1+/+ and Trpc1−/− mice, 3 days after injury. B, quantification of MHCd positive areas related to total muscle cross-section area. **, p < 0.01 versus Trpc1+/+ (Student's t test, n = 6 different mice per group). C, myogenic transcription factors activity measured using a luciferase-based gene reporter, related to the quantity of muscle protein content. *, p < 0.05 versus Trpc1+/+ (Student's t test, n = 6 different animals).

FIGURE 4.

FIGURE 4.

Expression of myogenic transcription factors in regenerating muscles. A, expression of myogenic factors (Myf5, MyoD, and myogenin) and p27 assessed by Western blot analysis in TA muscles. B, mRNA quantification (quantitative RT-PCR) of myogenic factors in EDL muscles. Δ_Ct_ was calculated by using GAPDH as internal control, and ΔΔ_Ct_ was related to the noninjected muscles in each group. *, p < 0.05 versus Trpc1+/+ at day 1 (two-way analysis of variance followed by Tukey's test for multiple comparison, n = 4 different animals per day).

FIGURE 5.

FIGURE 5.

Akt pathway in regenerating muscles. The level of Akt and p70S6K phosphorylation was quantified in TA muscles at day 3 of regeneration using Western blot analysis and was related to total Akt and p70S6K proteins contents, respectively. **, p < 0.01 versus Trpc1+/+ (A); *, p < 0.05 versus Trpc1+/+ (B); Student's t test (n = 6 different animals).

FIGURE 6.

FIGURE 6.

Involvement of Trpc1 in calcium-mediated primary myoblast differentiation. A, calcium influx in Trpc1+/+ and Trpc1−/− primary myoblasts estimated by using Mn2+-induced Fura-PE3 quenching technique. D0 represents proliferation condition, and D1 represents the first day of differentiation. **, p < 0.01 versus DO in Trpc1+/+ myoblasts; §, p < 0.05 between D1 Trpc1−/− and D1 Trpc1+/+ myoblasts (two-way analysis of variance followed by Bonferroni test for multiple comparison). B, wound healing assay performed in primary cultured myoblasts obtained from Trpc1+/+ and Trpc1−/− mice and maintained 24 h in differentiation medium (DM). C, number of migrating myoblasts 15 h after wounding (related to Trpc1+/+ migrating myoblast). ***, p < 0.001 versus Trpc1+/+ (Student's t test, representative data of three independent experiments). D, representative examples of Trpc1+/+ and Trpc1−/− myoblasts maintained in differentiation medium for 4 days.

FIGURE 7.

FIGURE 7.

Ca2+ modulation of Akt activation. A, immunodetection of Akt phosphorylation in C2C12 myoblasts maintained in proliferation medium (day 0) or cultured 1 day in differentiation medium (day 1). B, immunodetection of phosphorylated Akt in C2C12 myoblasts treated 24 h with 20 μ

m

EGTA-AM or vehicle only (dimethyl sulfoxide; DMSO), as a fraction of total Akt contents. *, p < 0.05 versus dimethyl sulfoxide; Student's t test (n = four different cultures). C, morphology of C2C12 myotubes after 5 days of differentiation; left panel, myoblasts treated with vehicle only; right panel, myoblasts treated at day 1 with 20 μ

m

EGTA-AM. D, immunodetection of phosphorylated Akt in C2C12 myoblasts maintained 4 h in differentiation medium with or without Ca2+ (200 μ

m

EGTA), as a fraction of total Akt contents. *, p < 0.05 versus control (Student's t test, n = 3 different cultures). E, comparison of phosphorylated Akt at day 1 of differentiation in Trpc1−/− and Trpc1+/+ primary myoblasts. F, immunodetection of phosphorylated Akt of Trpc1+/+ primary myoblasts cultured (PC) in proliferation medium (D0) and after 1 day in differentiation medium in the absence (D1) or in the presence of 100 n

m

wortmannin.

FIGURE 8.

FIGURE 8.

Involvement of Trpc1 in PI3K activation. Immunoprecipitation of phosphotyrosines residues followed by immunoblot of p85 subunit of PI3K (A) in C2C12 myoblasts cultured 1 day in differentiation medium and treated with or without EGTA-AM (B) in Trpc1+/+ and Trpc1−/− TA muscles after 3 days of regeneration. *, p < 0.05 versus Trpc1+/+; Student's t test (n = 6 different mice).

Comment in

Similar articles

Cited by

References

    1. Weintraub H. (1993) The MyoD family and myogenesis: Redundancy, networks, and thresholds. Cell 75, 1241–1244 - PubMed
    1. Buckingham M. (2001) Skeletal muscle formation in vertebrates. Curr. Opin. Genet. Dev. 11, 440–448 - PubMed
    1. Molkentin J. D., Olson E. N. (1996) Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. U.S.A. 93, 9366–9373 - PMC - PubMed
    1. Molkentin J. D., Black B. L., Martin J. F., Olson E. N. (1995) Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83, 1125–1136 - PubMed
    1. Halevy O., Novitch B. G., Spicer D. B., Skapek S. X., Rhee J., Hannon G. J., Beach D., Lassar A. B. (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267, 1018–1021 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources